Gilead Sciences (GILD) Current Deferred Tax Assets (2009 - 2016)

Gilead Sciences has reported Current Deferred Tax Assets for 8 years, with the latest figure at $857.0 million in Q4 2016.

• For the quarter ending Q4 2016, Current Deferred Tax Assets rose 3.5% year-over-year to $857.0 million; the trailing twelve-month figure through Dec 2016 stood at $857.0 million (up 3.5% YoY), and the FY2016 full-year result was $857.0 million, up 3.5% from the prior year.
• Current Deferred Tax Assets for Q4 2016 stood at $857.0 million, up from $762.0 million in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $894.0 million in Q3 2015, with the low at $193.9 million in Q1 2012.
• Historically, Current Deferred Tax Assets has averaged $501.1 million across 5 years, with a median of $385.6 million in 2014.
• Annual changes were most pronounced in 2012 — Current Deferred Tax Assets slumped 30.2% — and 2015, when it jumped 132.46%.
• Gilead Sciences' Current Deferred Tax Assets stood at $262.6 million in 2012, then gained by 26.03% to $331.0 million in 2013, then jumped by 53.47% to $508.0 million in 2014, then soared by 62.99% to $828.0 million in 2015, then grew by 3.5% to $857.0 million in 2016.
• The last three Current Deferred Tax Assets figures came in at $857.0 million (Q4 2016), $762.0 million (Q3 2016), and $835.0 million (Q2 2016), per Business Quant data.